Agen Biomedical Limited
Records under this name other than patents Agen Biomedical Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Agen Biomedical Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,087,724 | Carrier molecules Lapsed on the fee record Ended Aug 8, 2018 · USPTO record | Lapsed on the fee record | Ended Aug 8, 2018 | USPTO record |
| US 7,459,143 | Carrier molecules Lapsed on the fee record Ended Dec 2, 2016 · USPTO record | Lapsed on the fee record | Ended Dec 2, 2016 | USPTO record |
| US 4,758,524 | Monoclonal antibodies with specificity for crosslinked fibrin derivatives and assay for said derivatives Term ended Term ended no later than Jul 19, 2008 · Low confidence | Term ended | Term ended no later than Jul 19, 2008 | Low confidence |
| US 5,086,002 | Erythrocyte agglutination assay Term ended Term ended no later than Feb 4, 2012 · Low confidence | Term ended | Term ended no later than Feb 4, 2012 | Low confidence |
| US 5,413,913 | Erythrocyte agglutination assay Term ended Term ended no later than May 9, 2015 · Low confidence | Term ended | Term ended no later than May 9, 2015 | Low confidence |